This Program Is No Longer Active for Accreditation

We are leaving the website active for practitioners that wish to access the content.

Clinical Update on Advances in Managing Patients on Anticoagulation Therapy

A user account is required to view the accredited educational content on this site.

The Hospital Quality Foundation, CE Symmetry and CMEsolutions are excited to launch this innovative accredited educational activity. We are also proud to be able to partner with the developers of Body Interact™ to add a robust and exciting case management component to this activity. We appreciate your participation and welcome your feedback. 

Practitioners are increasingly faced with the clinical challenge of managing patients that require surgery or other invasive interventions. In this program, a concise didactic lecture on repletion therapy and NOAC reversal is accompanied by a brief tutorial on the simulation technology that will demonstrate how to work through a patient simulation case. This tutorial is designed to maximize the user experience.

Participants are provided access to three patient case simulations focusing on the management of patients on anticoagulation therapy that require additional medical interventions. In each patient simulation, multiple diagnostic and therapeutic options are available requiring participants to manage their “patients” in the face of real-time responses. For example, if a patient is hypotensive from a pelvic fracture and opioid analgesia is administered prior to fluid resuscitation, the patient’s vital signs will deteriorate as they would in the real world clinical setting requiring your immediate response. 

Following completion of each patient simulation, there is a full and customized debrief of the learner's case management, including a review of optimal and evidence-based choices, and feedback on the user’s choices. This feedback provides a timeline view of all patient management decisions, a review of your diagnosis and a performance feedback element.

This accredited educational activity is supported by a grant from Boehringer Ingelheim Pharmaceuticals, Inc.